Neil Gildener‐Leapman
Papers
1
Total Citations
37
H-Index
1
About
Dr. Neil Gildener‐Leapman is a head and neck surgeon whose research focuses on refining treatment paradigms for oropharyngeal cancer, particularly through the strategic use of transoral robotic surgery (TORS). His major contribution lies in demonstrating how up-front TORS can be leveraged to individually tailor adjuvant therapy, reducing unnecessary treatment intensity for select patients. In his highly cited 2016 study (37 citations), he analyzed 76 patients and showed that pathology from TORS allows clinicians to de-escalate chemoradiation, minimizing toxicity without compromising oncologic outcomes. This work has helped shift the field toward more personalized, function-preserving approaches in head and neck oncology. Dr. Gildener‐Leapman’s research bridges surgical innovation and precision medicine, offering a roadmap for integrating robotic techniques into multidisciplinary care. His impact is evident in the continued clinical adoption of TORS for treatment de-intensification, influencing both practice guidelines and patient quality of life. For students and researchers, his work exemplifies how surgical data can drive smarter, less morbid cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1Utility of up‐front transoral robotic surgery in tailoring adjuvant therapy37 citations · 2016